TechNavio's analysts forecast the Global In Vitro Diagnostics (IVD) Products
and Test market to grow at a CAGR of 4.33 percent over the period 2012-2016.
One of the key factors contributing to this market growth is the significant
growth of the IVD market in emerging countries. The market has also been
witnessing a significant increase in the number of acquisitions of small and
medium companies. However, the emergence of counterfeit or duplicate IVD
products could pose a challenge to the growth of this market.
To Read The Complete Report with TOC :-
TechNavio's report, the Global IVD Products and Test Market -
Strategic Volume and Pricing Analysis 2012-2016, has been prepared based on an
in-depth market analysis with inputs from industry experts. The report covers
the market in the Americas, and the APAC and EMEA regions and its growth
prospects in the coming years. The report also includes a discussion of the key
vendors operating in this market.
The key vendors dominating this space include Abbott
Laboratories, Becton Dickinson and Company, bioMerieux SA, F. Hoffmann-La Roche
Ltd., and Siemens Healthcare.
The other vendors mentioned in the report are 23andMe Inc., A.
Menarini Diagnostics S.r.l., Affymetrix Inc., Agilent Technologies Inc., Alere
Inc., ARKRAY Inc., Arrayit Diagnostics Inc, Astra Biotech GmbH, Axis-Shield
plc, Beckman Coulter Inc., BG Medicine Inc., Bio-Rad Laboratories Inc., Bruker
BioSciences Corp., Caliper Life Sciences Inc., Celera Diagnostics LLC, Cepheid
Inc., China Medical Technologies Inc., Dako A/S, Danaher Corp., DiaSorin S.p.A.,
Eiken Chemical Co. Ltd., ELITech SA, Enzo Biochem Inc., Epigenomics AG,
Fujirebio Diagnostics Inc., GE Healthcare, Grifols SA, Horiba Ltd., Idaho
Technology Inc., Illumina Inc., Innogenetics NV, Instrumentation Laboratory
Company, International Technidyne Corp., Intrinsic Bioprobes Inc., IRIS
International Inc., Life Technologies Corp., Linkage Biosciences Inc., Luminex
Corp., Magellan Biosciences Inc., Millipore Corp., Mitsubishi Chemical Medience
Corp., Nanosphere Inc., Nanosphere Inc., Nova Biomedical Corp., Novartis AG,
OPTI Medical Systems Inc., OptiGene Ltd., Ortho-Clinical Diagnostics Inc.,
PerkinElmer Inc., Phadia AB, Polymedco Inc., QIAGEN N.V., Quidel Corp., Radient
Pharmaceuticals Corp., Radiometer A/S, Randox Laboratories Ltd., Seegene Inc.,
SensiGen LLC, Sequenom Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd.,
Spartan Bioscience Inc., Sysmex Corp., TessArae LLC, Thermo Fisher Scientific
Inc., Tosoh Corp., Transasia Bio-Medicals Ltd., Transgenomic Inc., TrimGen
Corp., Trinity Biotech plc, TrovaGene Inc., Ventana Medical Systems Inc.,
Veridex LLC, Vermillion Inc., Wako Pure Chemical Industries Ltd., and Werfen
Life Group SA.
To Buy a Copy Of This Report:-
Key questions answered in this report:
·
What
will the market size be in 2015 and at what will be the growth rate?
·
What
are key market trends?
·
What
is driving this market?
·
What
are the challenges to market growth?
·
Who
are the key vendors in this market space?
·
What
are the market opportunities and threats faced by key vendors?
·
What
are the strengths and weaknesses of each of these key vendors?
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
No comments:
Post a Comment